ROS-mediated amplification of AKT/mTOR signalling pathway leads to myeloproliferative syndrome in Foxo3 -/- mice

Safak Yalcin, Dragan Marinkovic, Sathish Kumar Mungamuri, Xin Zhang, Wei Tong, Rani Sellers, Saghi Ghaffari

Research output: Contribution to journalArticle

84 Citations (Scopus)

Abstract

Reactive oxygen species (ROS) participate in normal intracellular signalling and in many diseases including cancer and aging, although the associated mechanisms are not fully understood. Forkhead Box O (FoxO) 3 transcription factor regulates levels of ROS concentrations, and is essential for maintenance of hematopoietic stem cells. Here, we show that loss of Foxo3 causes a myeloproliferative syndrome with splenomegaly and increased hematopoietic progenitors (HPs) that are hypersensitive to cytokines. These mutant HPs contain increased ROS, overactive intracellular signalling through the AKT/mammalian target of rapamycin signalling pathway and relative deficiency of Lnk, a negative regulator of cytokine receptor signalling. In vivo treatment with ROS scavenger N-acetyl-cysteine corrects these biochemical abnormalities and relieves the myeloproliferation. Moreover, enforced expression of Lnk by retroviral transfer corrects the abnormal expansion of Foxo3 -/- HPs in vivo. Our combined results show that loss of Foxo3 causes increased ROS accumulation in HPs. In turn, this inhibits Lnk expression that contributes to exaggerated cytokine responses that lead to myeloproliferation. Our findings could explain the mechanisms by which mutations that alter Foxo3 function induce malignancy. More generally, the work illustrates how deregulated ROS may contribute to malignant progression.

Original languageEnglish (US)
Pages (from-to)4118-4131
Number of pages14
JournalEMBO Journal
Volume29
Issue number24
DOIs
StatePublished - Dec 15 2010

Fingerprint

Amplification
Reactive Oxygen Species
Acetylcysteine
Transcription Factor 3
Cytokines
Cytokine Receptors
Splenomegaly
Sirolimus
Hematopoietic Stem Cells
Stem cells
Cysteine
Neoplasms
Aging of materials
Maintenance
Mutation

Keywords

  • FoxO
  • Lnk
  • mTOR
  • myeloproliferation
  • ROS

ASJC Scopus subject areas

  • Molecular Biology
  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)
  • Neuroscience(all)

Cite this

Yalcin, S., Marinkovic, D., Mungamuri, S. K., Zhang, X., Tong, W., Sellers, R., & Ghaffari, S. (2010). ROS-mediated amplification of AKT/mTOR signalling pathway leads to myeloproliferative syndrome in Foxo3 -/- mice. EMBO Journal, 29(24), 4118-4131. https://doi.org/10.1038/emboj.2010.292

ROS-mediated amplification of AKT/mTOR signalling pathway leads to myeloproliferative syndrome in Foxo3 -/- mice. / Yalcin, Safak; Marinkovic, Dragan; Mungamuri, Sathish Kumar; Zhang, Xin; Tong, Wei; Sellers, Rani; Ghaffari, Saghi.

In: EMBO Journal, Vol. 29, No. 24, 15.12.2010, p. 4118-4131.

Research output: Contribution to journalArticle

Yalcin, S, Marinkovic, D, Mungamuri, SK, Zhang, X, Tong, W, Sellers, R & Ghaffari, S 2010, 'ROS-mediated amplification of AKT/mTOR signalling pathway leads to myeloproliferative syndrome in Foxo3 -/- mice', EMBO Journal, vol. 29, no. 24, pp. 4118-4131. https://doi.org/10.1038/emboj.2010.292
Yalcin, Safak ; Marinkovic, Dragan ; Mungamuri, Sathish Kumar ; Zhang, Xin ; Tong, Wei ; Sellers, Rani ; Ghaffari, Saghi. / ROS-mediated amplification of AKT/mTOR signalling pathway leads to myeloproliferative syndrome in Foxo3 -/- mice. In: EMBO Journal. 2010 ; Vol. 29, No. 24. pp. 4118-4131.
@article{124a84d5fe094c93bfee6f8160cae1e8,
title = "ROS-mediated amplification of AKT/mTOR signalling pathway leads to myeloproliferative syndrome in Foxo3 -/- mice",
abstract = "Reactive oxygen species (ROS) participate in normal intracellular signalling and in many diseases including cancer and aging, although the associated mechanisms are not fully understood. Forkhead Box O (FoxO) 3 transcription factor regulates levels of ROS concentrations, and is essential for maintenance of hematopoietic stem cells. Here, we show that loss of Foxo3 causes a myeloproliferative syndrome with splenomegaly and increased hematopoietic progenitors (HPs) that are hypersensitive to cytokines. These mutant HPs contain increased ROS, overactive intracellular signalling through the AKT/mammalian target of rapamycin signalling pathway and relative deficiency of Lnk, a negative regulator of cytokine receptor signalling. In vivo treatment with ROS scavenger N-acetyl-cysteine corrects these biochemical abnormalities and relieves the myeloproliferation. Moreover, enforced expression of Lnk by retroviral transfer corrects the abnormal expansion of Foxo3 -/- HPs in vivo. Our combined results show that loss of Foxo3 causes increased ROS accumulation in HPs. In turn, this inhibits Lnk expression that contributes to exaggerated cytokine responses that lead to myeloproliferation. Our findings could explain the mechanisms by which mutations that alter Foxo3 function induce malignancy. More generally, the work illustrates how deregulated ROS may contribute to malignant progression.",
keywords = "FoxO, Lnk, mTOR, myeloproliferation, ROS",
author = "Safak Yalcin and Dragan Marinkovic and Mungamuri, {Sathish Kumar} and Xin Zhang and Wei Tong and Rani Sellers and Saghi Ghaffari",
year = "2010",
month = "12",
day = "15",
doi = "10.1038/emboj.2010.292",
language = "English (US)",
volume = "29",
pages = "4118--4131",
journal = "EMBO Journal",
issn = "0261-4189",
publisher = "Nature Publishing Group",
number = "24",

}

TY - JOUR

T1 - ROS-mediated amplification of AKT/mTOR signalling pathway leads to myeloproliferative syndrome in Foxo3 -/- mice

AU - Yalcin, Safak

AU - Marinkovic, Dragan

AU - Mungamuri, Sathish Kumar

AU - Zhang, Xin

AU - Tong, Wei

AU - Sellers, Rani

AU - Ghaffari, Saghi

PY - 2010/12/15

Y1 - 2010/12/15

N2 - Reactive oxygen species (ROS) participate in normal intracellular signalling and in many diseases including cancer and aging, although the associated mechanisms are not fully understood. Forkhead Box O (FoxO) 3 transcription factor regulates levels of ROS concentrations, and is essential for maintenance of hematopoietic stem cells. Here, we show that loss of Foxo3 causes a myeloproliferative syndrome with splenomegaly and increased hematopoietic progenitors (HPs) that are hypersensitive to cytokines. These mutant HPs contain increased ROS, overactive intracellular signalling through the AKT/mammalian target of rapamycin signalling pathway and relative deficiency of Lnk, a negative regulator of cytokine receptor signalling. In vivo treatment with ROS scavenger N-acetyl-cysteine corrects these biochemical abnormalities and relieves the myeloproliferation. Moreover, enforced expression of Lnk by retroviral transfer corrects the abnormal expansion of Foxo3 -/- HPs in vivo. Our combined results show that loss of Foxo3 causes increased ROS accumulation in HPs. In turn, this inhibits Lnk expression that contributes to exaggerated cytokine responses that lead to myeloproliferation. Our findings could explain the mechanisms by which mutations that alter Foxo3 function induce malignancy. More generally, the work illustrates how deregulated ROS may contribute to malignant progression.

AB - Reactive oxygen species (ROS) participate in normal intracellular signalling and in many diseases including cancer and aging, although the associated mechanisms are not fully understood. Forkhead Box O (FoxO) 3 transcription factor regulates levels of ROS concentrations, and is essential for maintenance of hematopoietic stem cells. Here, we show that loss of Foxo3 causes a myeloproliferative syndrome with splenomegaly and increased hematopoietic progenitors (HPs) that are hypersensitive to cytokines. These mutant HPs contain increased ROS, overactive intracellular signalling through the AKT/mammalian target of rapamycin signalling pathway and relative deficiency of Lnk, a negative regulator of cytokine receptor signalling. In vivo treatment with ROS scavenger N-acetyl-cysteine corrects these biochemical abnormalities and relieves the myeloproliferation. Moreover, enforced expression of Lnk by retroviral transfer corrects the abnormal expansion of Foxo3 -/- HPs in vivo. Our combined results show that loss of Foxo3 causes increased ROS accumulation in HPs. In turn, this inhibits Lnk expression that contributes to exaggerated cytokine responses that lead to myeloproliferation. Our findings could explain the mechanisms by which mutations that alter Foxo3 function induce malignancy. More generally, the work illustrates how deregulated ROS may contribute to malignant progression.

KW - FoxO

KW - Lnk

KW - mTOR

KW - myeloproliferation

KW - ROS

UR - http://www.scopus.com/inward/record.url?scp=78650302424&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650302424&partnerID=8YFLogxK

U2 - 10.1038/emboj.2010.292

DO - 10.1038/emboj.2010.292

M3 - Article

VL - 29

SP - 4118

EP - 4131

JO - EMBO Journal

JF - EMBO Journal

SN - 0261-4189

IS - 24

ER -